Fusion Research - Quick Take - Compuware (CPWR) - Defensive Long

Embed Size (px)

Citation preview

  • 8/23/2019 Fusion Research - Quick Take - Compuware (CPWR) - Defensive Long

    1/3

    4/22/201

    Fusion Quick Tak

    Fusion Analytics Research Partners LLC 2013 All Rights Reserved

    Quick Defensive Technology - Long Idea

    We would be buyers of CPWR after this pullback, post their negative Q4 pre announcement on April 3 rd. In

    January they rejected a $2.3 billion or $11/share takeover offer from activist Elliot advisors. They have since

    hired Goldman and Allen as their advisors. There have been other potential bidders floated in the press such as

    private equity firms Thoma Bravo, Golden Gate Capital and Apax Partners. Additionally, Bloomberg ran a story

    on April 8th that Compuware is in early stage management meetings with private equity suitors. Longtime

    chairman Peter Karmanos Jr. retired on March 31st, and in an 8-k filing from October, will remain on as a

    consultant for 6 years collecting $600,000 per year. He currently owns 6,135,571 shares. At the current price of

    $11.40 I believe the downside is limited and think this is a perfect defensive long idea for this tape. CPWR

    officially reports on May 21st and I would not be surprised to see the stock rally into numbers on expectations of

    some kind of M&A resolution.

    Valuation

    In October 2012, RVBD bought APM vendor OPNT at an enterprise value of $921M a competitor to CPWR at

    approximately 5x EV/2012 sales. CPWRs APM business run rate is approximately $315M or equivalent to a $1.5B

    valuation based on OPNTs price. The Covasint IPO spinout is worth anywhere from $ 400-700m, with an

    expected $100M run rate in 2013, growing around 35% year over year. This should happen this summer. This

    values the mainframe, services and other business at close to nothing since CPWRs current market cap is $2.3B.

    I can justify a $13-14 price target or 2.8-3 x EV/sales.

    Please see technical, outlook for CPRW on the next page

    Compuware Corp. (CPWR) - NASDAQ $ 11.40Industry Group: Software Market Cap: $2.42 Billiomn Marc Lewis 1 (415) - [email protected]

  • 8/23/2019 Fusion Research - Quick Take - Compuware (CPWR) - Defensive Long

    2/3

    4/22/201

    Fusion Quick Tak

    Fusion Analytics Research Partners LLC 2013 All Rights Reserved

    Technical Outlook for CPWR

    As seen in the chart below CPWR shares are pulled back this AM to its first support level (orange line) near

    $11.20 and are bouncing. Additional solid support lies in the $ 10.60 - $ 10.30 area (green band). Resistance

    lies near $ 12.62 (red line). The current action looks like a healthy pullback after challenging resistance recently.

    We would be scaled buyers here and A secondary supports if shares pull in further. We then see shares testing

    the 2001/2002 highs near $ 14.00, which aligns with our valuation thesis.

    CPWR - Weekly Chart, through last intraday tick

  • 8/23/2019 Fusion Research - Quick Take - Compuware (CPWR) - Defensive Long

    3/3

    4/22/201

    Fusion Quick Tak

    Fusion Analytics Research Partners LLC 2013 All Rights Reserved

    Important Disclosures

    This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of

    any financial instrument or as an official confirmation of any transaction. All market prices, data and other information are not

    warranted as to completeness or accuracy and are subject to change without notice. Any comments or statements made herein

    do not necessarily reflect those of Fusion Holdings LLC, its subsidiaries and affiliates. This transmission may contain information

    that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the

    intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein

    (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free

    of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of

    the recipient to ensure that it is virus free and no responsibility is accepted by Fusion Holdings LLC., its subsidiaries and affiliates,

    as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please

    immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format.

    Fusion Analytics Research Partners LLC (FARP) is not registered as an investment adviser with the SEC or any state securities

    agency. Rather, FARP relies upon the publishers exclusion from the definition of investment adviser as provided under

    Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. The site content and services

    offered thereon are bona fide publications of general and regular circulation offering impersonalized investment-related

    information to users and/or prospective users (e.g., not tailored to the specific investment needs of current and/or prospective

    users). To the extent any of the content published as part of the site or services offered thereon may be deemed to be

    investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Past

    Performance is not guarantee of future performance. This is not an offer or solicitation to buy or sell a security, the information

    herein is presented for informational purposes only. At the time of the publishing of this research report Fusion Analytics

    Investment Partners LLC, an affiliated entity, does not own positions in - CPWRshares for accounts of privately managed clients

    for which it provides investment advisory services. The analyst that published this report also does not own any - CPWR sharespersonally and is free from conflict. No Fusion related entity does any investment banking with the company mentioned in thisreport, nor does the firm make markets in any shares mentioned in this report.